cagrilintide — 17 things I got wrong before I got it right
cagrilintide — 17 things I got wrong before I got it right, which sounds obvious until you try to state the evidence for it.
Dosing intuitions from the GLP-1 boards do not transfer. Different receptor family, different exposure-response, and no published schedule for members to reason from.
Carried an assumption over from the tirzepatide board and was corrected within an hour. Deserved.
Read the combination paper twice before saying anything here. The monotherapy and combination arms tell genuinely different stories.
If somebody has the same thing measured a different way, post it next to mine and we will see whether they agree.
best — the order this archive was captured in
Complementary mechanisms are the rationale for pairing: satiety signalling alongside incretin signalling, rather than more agonism at the same receptor.
Push back: the evidence base here is thin enough that a confident ranking against the established compounds is not supportable.
phase 3 data will change most of what gets said here
Standing reminder: nothing here is approved standalone, research material is not for human use, and no dosing schedules for other members.
Careful — that is a dosing intuition carried over from another board and there is no basis for it here.
Yes. Anyone reading this board should hold their conclusions loosely until phase 3 reports.
Went looking for independent results on this and found a handful across the whole site. That is the honest state of the evidence.
That is preclinical work and the thread is treating it as a human finding.
Bought small deliberately because the evidence base is thin. That felt like the only defensible approach.
Nothing containing this compound is approved as a standalone product, and research-use-only material is not approved for human use.
- 1Complementary mechanisms are the rationale for pairing: satiety signalling…6 comments in this branch · started by u/signe_grimaldi